Literature DB >> 10227075

l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.

E Cavazzuti1, A Bertolini, A V Vergoni, R Arletti, R Poggioli, A Forgione, A Benelli.   

Abstract

Antidepressant drugs are effective in anxiety states, including panic disorder. Both clinical and animal studies indicate that l-sulpiride, at low, non-neuroleptic doses, has antidepressant activity. The present study examined the effect of an antidepressant dose of l-sulpiride (4 mg/kg per day SC), compared with a well-established antidepressant drug (fluoxetine, 3 mg/kg per day SC), in a rat model of anticipatory anxiety/panic behavior: conditioned fear stress-induced freezing behavior. Long-term (26 days) administration of l-sulpiride almost completely abolished freezing, a similar effect being produced by fluoxetine (freezing duration, in seconds: controls, 148.1 +/- 29.6; l-sulpiride, 27.5 +/- 8.3; fluoxetine, 72.0 +/- 15.2). The same doses of l-sulpiride (4 mg/kg SC) and fluoxetine (3 mg/kg SC) had no effect when administered for shorter periods (1, 5, or 12 days). No effect was produced by the long-term (26 days) administration of a neuroleptic dose of l-sulpiride (20 mg/kg per day SC). These results demonstrate that long-term administration of low, non-neuroleptic doses of l-sulpiride, is highly effective in an animal model of anticipatory anxiety/panic behavior.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227075     DOI: 10.1007/s002130050914

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

1.  Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.

Authors:  Olivier Deschaux; Guillaume Spennato; Jean-Luc Moreau; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  Sulpiride and refractory panic disorder.

Authors:  Emerson A Nunes; Rafael C Freire; Moema Dos Reis; Adriana Cardoso de Oliveira E Silva; Sérgio Machado; José A S Crippa; Serdar M Dursun; Glen B Baker; Jaime E C Hallak; Antonio E Nardi
Journal:  Psychopharmacology (Berl)       Date:  2012-08-05       Impact factor: 4.530

3.  Fluoxetine protects hippocampal plasticity during conditioned fear stress and prevents fear learning potentiation.

Authors:  Guillaume Spennato; Carine Zerbib; Cesare Mondadori; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2007-11-09       Impact factor: 4.530

Review 4.  Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review.

Authors:  Vasilios G Masdrakis; David S Baldwin
Journal:  Ther Adv Psychopharmacol       Date:  2021-03-21

5.  A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.

Authors:  James M Prosser; Samantha Yard; Annie Steele; Lisa J Cohen; Igor I Galynker
Journal:  BMC Psychiatry       Date:  2009-05-26       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.